| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/17/2002 | US6451541 Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPsc |
| 09/17/2002 | US6451538 Antisense modulation of CHK2 expression |
| 09/17/2002 | US6451536 Products for detecting nucleic acids |
| 09/17/2002 | US6451535 Composition containing DNA coding for a ribozyme and an oligonucleotide substrate, and method for measuring transcription rates |
| 09/17/2002 | US6451534 Kvlqt1 and kcne1 which are genes associated with long qt syndrome. additional sequence data for the two genes are also disclosed. mutations in kvlqt1 which result in long qt syndrome. the intron/exon junction sequence data allow for the |
| 09/17/2002 | US6451533 FldA gene and methods for detecting predisposition to mucosa-associated lymphoid tissue lymphoma of the stomach |
| 09/17/2002 | US6451532 Diagnosing; determining the stage of; and monitoring the effect of a therapeutic intervention for a renal cell carcinoma in a human subject which comprises detecting the expression of the mn gene. |
| 09/17/2002 | US6451531 Dioxetane labeled probes and detection assays employing the same |
| 09/17/2002 | US6451530 Detection of nucleic acid interactions with other nucleic acids or with proteins. the methods generally utilize a nucleic acid (e.g., an oligonucleotide) that contains one or more fluorescent nucleotide analogues to form a loop |
| 09/17/2002 | US6451529 Probes for the detection of prostate cancer cells. the probes bind selectively with target polynucleotide sequences selected from the group |
| 09/17/2002 | US6451528 Isolated nucleic acid encoding sperm-specific protein kinase a anchoring proteins from mammalian species, recombinant expression constructs encoding said mammalian sperm-specific protein kinase a anchoring proteins, cells transformed with |
| 09/17/2002 | US6451527 A method of selecting internalizing ligands displayed on a genetic package from a library of ligand displaying genetic packages, comprising: contacting a library of ligand displaying genetic packages with a cell and detection of |
| 09/17/2002 | US6451526 Oligonucleotides and diagnostic kits that can be used to amplify nucleic acid sequences such that if heterologous amplified fragments are present, then stable nucleic acid branching structures are formed and detected from a cell |
| 09/17/2002 | US6451525 Parallel sequencing method |
| 09/17/2002 | US6451524 Identification of disease predictive nucleic acids |
| 09/17/2002 | US6451523 Variant form of the receptor for the obese gene product. the invention relates to methods of detecting this receptor variant in cells and tissues of obese individuals. |
| 09/17/2002 | US6451522 Combining agent to be tested, antibody or antigen-binding fragment which binds to amino terminal domain of mammalian cc-chemokine receptor 2, mammalian cc-chemokine receptor 2 or ligand-binding variant, measuring binding |
| 09/17/2002 | US6451372 Biosensor and method of producing the same |
| 09/17/2002 | US6451368 Administering milk from lactating cow producing milk with casein variant having proline at position 67 instead of histidine |
| 09/17/2002 | US6451315 Compounds and methods for the diagnosis and treatment of B. microti infection |
| 09/17/2002 | US6451310 Preventing t cell activation of b cells by administering antibody cabable of binding protein recognized by monoclonal antibody 5c8 |
| 09/17/2002 | US6451260 Method for producing microporous elements, the microporous elements thus produced and uses thereof |
| 09/17/2002 | US6451225 Mixtures of chelate compounds, amines and electrolytes used for chemical and quantitative analysis; detection of electromagnetic radiations emitted; accuracy |
| 09/17/2002 | US6451196 Biosensors having ionophores in lipid membrane coatings on metal electrodes; applying direct currents voltages superimposed onto alternating current impedance signals to influence conductivity; sensitivity |
| 09/17/2002 | US6451191 Film based addressable programmable electronic matrix articles and methods of manufacturing and using the same |
| 09/17/2002 | CA2278878C Very large scale immobilized peptide synthesis |
| 09/17/2002 | CA2242693C Additive formulation and method of use thereof |
| 09/17/2002 | CA2228836C Detection of periodontal pathogens including bacteroides forsythus, porphyromonas, gingivalis, prevotella intermedia and prevotella nigrescens |
| 09/17/2002 | CA2145405C Nucleotides labelled with an infrared dye and their use in nucleic acid detection |
| 09/17/2002 | CA2131543C Comparative genomic hybridization |
| 09/17/2002 | CA2082933C Method and means to perform biochemical reactions |
| 09/17/2002 | CA2042974C Use of a 1-(2-naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for the manufacture of a medicament for the treatment of cerebral and neuronal diseases |
| 09/16/2002 | CA2373468A1 Reg-like protein |
| 09/12/2002 | WO2002071074A2 Method for analyzing proteins |
| 09/12/2002 | WO2002071070A2 β-ADRENOCEPTOR GENETIC POLYMORPHISMS AND OBESITY |
| 09/12/2002 | WO2002071068A1 Method for detecting macromolecular biopolymers by using at least one immobilizing unit provided with a marked scavenger molecule |
| 09/12/2002 | WO2002071064A1 Method of examining steroid-responsiveness |
| 09/12/2002 | WO2002071060A2 Use of metabolic phenotyping in individualized treatment with amonafide |
| 09/12/2002 | WO2002071055A1 Automated immunohistochemical and in situ hybridzation assay formulations |
| 09/12/2002 | WO2002071044A1 Distinguishing test types through spectral analysis |
| 09/12/2002 | WO2002071040A2 Use of infrared spectroscopy in genotypic analysis |
| 09/12/2002 | WO2002070755A2 Fen endonucleases |
| 09/12/2002 | WO2002070752A1 Assay for hepatitis c virus helicase (ns3) rna binding |
| 09/12/2002 | WO2002070751A1 Pcr method |
| 09/12/2002 | WO2002070750A2 Method of determining dihydropyrimidine dehydrogenase gene expression |
| 09/12/2002 | WO2002070749A2 Methods and compositions for analyzing nucleic acids |
| 09/12/2002 | WO2002070748A2 Response of dendritic cells to a diverse set of pathogens |
| 09/12/2002 | WO2002070747A1 Method of molecular diagnosis of chronic myelogenous leukemia |
| 09/12/2002 | WO2002070746A2 Methods for global profiling gene regulatory element activity |
| 09/12/2002 | WO2002070745A2 Polymorphisms in the zf9 gene linked to a predisposition for the development of inappropriate scarring of fibrosis |
| 09/12/2002 | WO2002070744A2 Adenoviral library assay for e2f regulatory genes and methods and compositions for screening compounds |
| 09/12/2002 | WO2002070743A2 Identification and use of inhibitors of hair growth |
| 09/12/2002 | WO2002070742A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 09/12/2002 | WO2002070741A2 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 09/12/2002 | WO2002070740A2 Test system for determining gene toxicities |
| 09/12/2002 | WO2002070739A2 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv |
| 09/12/2002 | WO2002070738A2 Diagnosis and treatment of blood disorders |
| 09/12/2002 | WO2002070737A2 Compositions and methods relating to osteoarthritis |
| 09/12/2002 | WO2002070736A2 Method for the detection of nucleic acid molecules |
| 09/12/2002 | WO2002070735A2 Method for the amplification and detection of dna using a transcription based amplification |
| 09/12/2002 | WO2002070733A1 Method for detecting macromolecular biopolymers by using at least one nanoparticle provided with a scavenger molecule |
| 09/12/2002 | WO2002070732A2 Method for assaying non-spermine/spermidine activity of spermidine/spermine n1acetyltransferase (ssat) |
| 09/12/2002 | WO2002070731A2 Methods and primers for evaluating hiv-1 mutations |
| 09/12/2002 | WO2002070730A2 Models and methods for determining systemic properties of regulated reaction networks |
| 09/12/2002 | WO2002070729A2 Improved skin substitutes and uses thereof |
| 09/12/2002 | WO2002070728A2 Quantitative assay for the simultaneous detection and speciation of bacterial infections |
| 09/12/2002 | WO2002070727A2 Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam6, expressed highly in the small intestine |
| 09/12/2002 | WO2002070718A1 Dna encoding l-ribose isomerae and use thereof |
| 09/12/2002 | WO2002070708A2 Glutamate receptor modulatory proteins and nucleic acids encoding them |
| 09/12/2002 | WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | WO2002070703A2 Cell visual characteristic-modifying sequences |
| 09/12/2002 | WO2002070696A2 Cd109 nucleic acid molecules polypeptides and methods of use |
| 09/12/2002 | WO2002070695A2 Tumor associated proteins |
| 09/12/2002 | WO2002070689A1 Method of extracting virus gene and extraction apparatus |
| 09/12/2002 | WO2002070687A1 Highly sensitive nucleic acid hybridization method and gene analysis method by using the same |
| 09/12/2002 | WO2002070669A2 Secreted proteins |
| 09/12/2002 | WO2002070666A2 Compositions and methods for regulating autolytic processes in bacteria |
| 09/12/2002 | WO2002070664A2 Method for rapid detection and identification of bioagents |
| 09/12/2002 | WO2002070662A2 Three hybrid assay system |
| 09/12/2002 | WO2002070658A2 Compositions and methods for increasing amino acid absorption in mammals |
| 09/12/2002 | WO2002070657A2 93870, a human g-protein coupled receptor and uses therefor |
| 09/12/2002 | WO2002070655A2 Mouse cytokine receptor |
| 09/12/2002 | WO2002070651A2 Viral reporter particles |
| 09/12/2002 | WO2002070645A2 Functional surface display of polypeptides |
| 09/12/2002 | WO2002070563A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070562A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070561A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070560A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070559A2 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | WO2002070558A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070557A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070556A1 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF |
| 09/12/2002 | WO2002070555A2 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 09/12/2002 | WO2002070553A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | WO2002070552A2 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF |
| 09/12/2002 | WO2002070536A1 Antisense modulation of recql2 expression |
| 09/12/2002 | WO2002070535A1 Antisense modulation of recql5 expression |
| 09/12/2002 | WO2002070006A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 09/12/2002 | WO2002070003A1 Altered peptide ligands |
| 09/12/2002 | WO2002069908A2 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |